相似文献
1
Disodium cromoglycate in the treatment of chronic proctitis.
Gut. 1975 Jul;16(7):559-63. doi: 10.1136/gut.16.7.559.
2
Disodium cromoglycate in the treatment of chronic proctitis.
Acta Allergol. 1977;Suppl 13:87-94.
3
Proceedings: Treatment of chronic proctitis with disodium cromoglycate.
Gut. 1974 Oct;15(10):829.
4
Allergic proctitis, a clinical and immunopathological entity.
Gut. 1980 Dec;21(12):1017-23. doi: 10.1136/gut.21.12.1017.
5
Treatment of ulcerative colitis with oral disodium cromoglycate. A double-blind controlled trial.
Lancet. 1976 Feb 28;1(7957):439-41. doi: 10.1016/s0140-6736(76)91471-9.
6
Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.
Gut. 1978 Dec;19(12):1140-3. doi: 10.1136/gut.19.12.1140.
7
Local disodium cromoglycate is ineffective in ulcerative proctosigmoiditis.
Acta Med Scand. 1986;219(5):497-500. doi: 10.1111/j.0954-6820.1986.tb03345.x.
8
Disodium cromoglycate nasal spray in the treatment of perennial rhinitis.
Acta Otolaryngol. 1977 Sep-Oct;84(3-4):287-91. doi: 10.3109/00016487709123969.
9
Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement.
J Allergy Clin Immunol. 1984 Jul;74(1):41-8. doi: 10.1016/0091-6749(84)90085-x.
10
Clinical trial of the topical use of disodium cromoglycate in vernal, allergic and chronic conjunctivitis.
Acta Ophthalmol (Copenh). 1980;58(1):121-4. doi: 10.1111/j.1755-3768.1980.tb04574.x.
引用本文的文献
1
Mast Cells in Gut and Brain and Their Potential Role as an Emerging Therapeutic Target for Neural Diseases.
Front Cell Neurosci. 2019 Jul 30;13:345. doi: 10.3389/fncel.2019.00345. eCollection 2019.
2
Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.
Cells. 2019 Feb 22;8(2):193. doi: 10.3390/cells8020193.
3
The multifaceted mast cell in inflammatory bowel disease.
Inflamm Bowel Dis. 2014 Dec;20(12):2364-78. doi: 10.1097/MIB.0000000000000142.
4
Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice.
PLoS One. 2010 Aug 17;5(8):e12220. doi: 10.1371/journal.pone.0012220.
5
Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid-based formula induced remission in a patient with steroid-dependent, chronically active ulcerative colitis.
Int J Colorectal Dis. 2007 Jul;22(7):833-9. doi: 10.1007/s00384-006-0120-y. Epub 2006 Mar 31.
6
Ketotifen therapy for acute ulcerative colitis in children: a pilot study.
Dig Dis Sci. 1998 Mar;43(3):609-15. doi: 10.1023/a:1018827527826.
7
Dietary allergy and specific IgE in ulcerative colitis.
J R Soc Med. 1981 Apr;74(4):292-3. doi: 10.1177/014107688107400411.
8
Inhibition of gastric acid secretion with a mast cell stabiliser, FPL-52694.
Br J Clin Pharmacol. 1981 Jan;11(1):53-6. doi: 10.1111/j.1365-2125.1981.tb01101.x.
9
Assessment of drug therapy in inflammatory bowel disease.
Br J Clin Pharmacol. 1982 Aug;14(2):159-70. doi: 10.1111/j.1365-2125.1982.tb01957.x.
10
Mucosal immunology.
Immunology. 1980 Oct;41(2):249-70.
本文引用的文献
1
Gastrointestinal allergy in infancy; significance of eosinophiles in the stools.
Pediatrics. 1952 Mar;9(3):311-9.
2
CIRCULATING ANTIBODIES TO DIETARY PROTEINS IN ULCERATIVE COLITIS.
Br Med J. 1965 Jul 17;2(5454):142-4. doi: 10.1136/bmj.2.5454.142.
3
EOSINOPHILS AND ANTIGEN-ANTIBODY REACTIONS.
Ann N Y Acad Sci. 1964 Aug 27;116:964-85. doi: 10.1111/j.1749-6632.1964.tb52562.x.
4
EOSINOPHILIA IN PERIPHERAL BLOOD AND INFLAMMATORY EXUDATE IN NON-SPECIFIC PROCTOCOLITIS.
Acta Med Scand. 1964 Jan;175:85-9. doi: 10.1111/j.0954-6820.1964.tb00553.x.
5
VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS.
Br Med J. 1964 Jan 11;1(5375):89-92. doi: 10.1136/bmj.1.5375.89.
6
A double blind controlled trial of prednisolone-21-phosphate suppositories in the treatment of idiopathic proctitis.
Gut. 1962 Sep;3(3):207-10. doi: 10.1136/gut.3.3.207.
7
Observations on idiopathic proctitis.
Gut. 1962 Sep;3(3):201-6. doi: 10.1136/gut.3.3.201.
8
Mast cells in inflammatory conditions of the gastrointestinal tract.
Am J Gastroenterol. 1962 May;37:541-5.
9
Suppository treatment of haemorrhagic proctitis.
Br Med J. 1959 Apr 11;1(5127):955-8. doi: 10.1136/bmj.1.5127.955.
10
Ulceration of the rectum and terminal portion of the colon; significance in absence of malignant disease and chronic ulcerative colitis.
AMA Arch Surg. 1957 Dec;75(6):1029-35. doi: 10.1001/archsurg.1957.01280180161026.
Zotero 插件